相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
In Silico Design, Synthesis, and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity
Giulia Culletta et al.
PHARMACEUTICALS (2022)
CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy
Mahendar Porika et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Structure of active human telomerase with telomere shelterin protein TPP1
Baocheng Liu et al.
NATURE (2022)
Structural basis of human telomerase recruitment by TPP1-POT1
Zala Sekne et al.
SCIENCE (2022)
TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance
Valentina Buemi et al.
NATURE COMMUNICATIONS (2022)
Facile induction and stabilization of intramolecular antiparallel G-quadruplex of d(TTAGGG)n on interaction with triazine-2-imidazole ethyl amine compound and its Cu(II), Zn(II) complexes under no-salt conditions
Renuga Duraisamy et al.
JOURNAL OF CHEMICAL SCIENCES (2022)
Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
Xu Han et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
Stephen C. Frederico et al.
FRONTIERS IN ONCOLOGY (2021)
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
Espen Basmo Ellingsen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
Robert H. Vonderheide et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Luis Teixeira et al.
CLINICAL CANCER RESEARCH (2020)
Targeted Covalent Inhibition of Telomerase
Rick C. Betori et al.
ACS CHEMICAL BIOLOGY (2020)
Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy
Hiroshi Tazawa et al.
CANCERS (2020)
Small-molecule G-quadruplex stabilizers reveal a novel pathway of autophagy regulation in neurons
Jose F. Moruno-Manchon et al.
ELIFE (2020)
In silico design of telomerase inhibitors
Maciej Baginski et al.
DRUG DISCOVERY TODAY (2020)
Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection
Xindi Dang et al.
CELL DEATH & DISEASE (2020)
Telomeres and telomerase in oncogenesis
Tomasz Trybek et al.
ONCOLOGY LETTERS (2020)
The powerful world of antisense oligonucleotides: From bench to bedside
Anais M. Quemener et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
Targeting telomerase for its advent in cancer therapeutics
Shalini Bajaj et al.
MEDICINAL RESEARCH REVIEWS (2020)
Anti-Cancer Immunotherapies Targeting Telomerase
Simone Negrini et al.
CANCERS (2020)
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
Adam Eckburg et al.
CANCERS (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Compromised Chondrocyte Differentiation Capacity in TERC Knockout Mouse Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer
Wei-Fang Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length
Jenni Kesaniemi et al.
SCIENTIFIC REPORTS (2019)
Epigallocatechin-3-gallate induces telomere shortening and clastogenic damage in glioblastoma cells
Ion Udroiu et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2019)
Telomerase-Targeted Cancer Immunotherapy
Eishiro Mizukoshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeted and Persistent 8-Oxoguanine Base Damage at Telomeres Promotes Telomere Loss and Crisis
Elise Fouquerel et al.
MOLECULAR CELL (2019)
A non-natural nucleotide uses a specific pocket to selectively inhibit telomerase activity
Wilnelly Hernandez-Sanchez et al.
PLOS BIOLOGY (2019)
Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases
JinWoo Hong et al.
CELLS (2019)
Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes
Zahra Ameri et al.
LIFE SCIENCES (2019)
Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death
Rui Liu et al.
CELL DEATH & DISEASE (2019)
BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition
Xiaofeng Ding et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
Zhan-Fang Fan et al.
MOLECULES (2019)
A 9-chloro-5,6,7,8-tetrahydroacridine Pt(II) complex induces apoptosis of Hep-G2 cells via inhibiting telomerase activity and disrupting mitochondrial pathway
Shu-Long Wang et al.
INORGANIC CHEMISTRY COMMUNICATIONS (2019)
Cancer overdiagnosis: a biological challenge and clinical dilemma
Sudhir Srivastava et al.
NATURE REVIEWS CANCER (2019)
Telomerase Inhibitors from Natural Products and Their Anticancer Potential
Kumar Ganesan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Human DNA Repair Genes Possess Potential G-Quadruplex Sequences in Their Promoters and 5 '-Untranslated Regions
Aaron M. Fleming et al.
BIOCHEMISTRY (2018)
Targeting G-quadruplex DNA structures in the telomere and oncogene Promoter regions by benzimidazole-carbazole ligands
Mangesh H. Kaulage et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Correlation between telomerase and mTOR pathway in cancer stem cells
Fatma Dogan et al.
GENE (2018)
Telomerase Inhibition by a New Synthetic Derivative of the Aporphine Alkaloid Boldine
Sakineh Kazemi Noureini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis
Cagatay Guenes et al.
NATURE REVIEWS UROLOGY (2018)
Leukocyte Telomere Length and Pancreatic Cancer Risk: Updated Epidemiologic Review
Samuel O. Antwi et al.
PANCREAS (2018)
Comprehensive analysis of telomerase inhibition by gallotannin
Nikita Savelyev et al.
Oncotarget (2018)
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
Igen Mender et al.
NEOPLASIA (2018)
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality
Yingbo Lin et al.
MODERN PATHOLOGY (2018)
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
Andrew T. Ludlow et al.
NATURE COMMUNICATIONS (2018)
Immunotherapy in Glioblastoma
Jessica A. Wilcox et al.
WORLD NEUROSURGERY (2018)
Revitalizing the AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Cell Line
Monica Silveira Wagner et al.
FRONTIERS IN ONCOLOGY (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis
P. Gu et al.
ONCOGENE (2017)
Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells
Ke-Wei Ren et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Telomere-driven diseases and telomere-targeting therapies
Paula Martinez et al.
JOURNAL OF CELL BIOLOGY (2017)
The Hammerhead Ribozyme: A Long History for a Short RNA
Marcos de la Pena et al.
MOLECULES (2017)
Telomerase based anticancer immunotherapy and vaccines approaches
Chahal Kailashiya et al.
VACCINE (2017)
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
Yue Yu et al.
CELL DEATH & DISEASE (2017)
Telomere Biology-Insights into an Intriguing Phenomenon
Shriram Venkatesan et al.
CELLS (2017)
Synthetic Nucleic Acid Analogues in Gene Therapy: An Update for Peptide-Oligonucleotide Conjugates
Maria Taskova et al.
CHEMBIOCHEM (2017)
Telomerase Inhibition and Human Telomeric G-Quadruplex DNA Stabilization by a β-Carboline-Benzimidazole Derivative at Low Concentrations
Kranthikumar Yadav et al.
BIOCHEMISTRY (2017)
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α
Ugo Perricone et al.
CHEMMEDCHEM (2017)
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
Wolfgang Lilleby et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro
S. Yano et al.
CANCER GENE THERAPY (2017)
Treating Cancer by Targeting Telomeres and Telomerase
Marko Ivancich et al.
ANTIOXIDANTS (2017)
Association between telomere length and the risk of colorectal cancer: a meta-analysis of observational studies
Cho Naing et al.
BMC CANCER (2017)
Widespread telomere instability in prostatic lesions
LiRen Tu et al.
MOLECULAR CARCINOGENESIS (2016)
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response
Jessie Thalmensi et al.
ONCOIMMUNOLOGY (2016)
Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects
Xuan Xiao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia
Christian Bar et al.
BLOOD (2016)
Telomerase as a Cancer Target. Development of New Molecules
D. L. Mengual Gomez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo
Jing Bo Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Telomerase inhibitors: a patent review (2010-2015)
Ruo-Jun Man et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Telomerase Inhibitors: Potential Anticancer Agents
Rakesh R. Somani et al.
MINI-REVIEWS IN ORGANIC CHEMISTRY (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
Telomere and Telomerase Therapeutics in Cancer
Yucheng Xu et al.
GENES (2016)
The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma
Yafang Hu et al.
CANCER BIOLOGY & THERAPY (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Telomerase: a target for colorectal cancer treatment?
Elias Kouroumalis
CELL CYCLE (2015)
Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations
Sakineh Kazemi Noureini et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Novel myricetin derivatives: Design, synthesis and anticancer activity
Wei Xue et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: Synthesis and anticancer activity
Jing Bo Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Beginning at the end: DNA replication within the telomere
Susan A. Gerbi
JOURNAL OF CELL BIOLOGY (2015)
DCAF4, a novel gene associated with leucocyte telomere length
Massimo Mangino et al.
JOURNAL OF MEDICAL GENETICS (2015)
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
Lynnette R. Ferguson et al.
SEMINARS IN CANCER BIOLOGY (2015)
Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532
Christopher Bryan et al.
STRUCTURE (2015)
Expression of human protection of telomere 1 correlates with telomere length and radiosensitivity in the human laryngeal cancer Hep-2 cell line
Han Lei et al.
ONCOLOGY LETTERS (2015)
Perifosine as a potential novel anti-telomerase therapy
Brody Holohan et al.
ONCOTARGET (2015)
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
Daniela Fenoglio et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Telomerase activity in the occurrence and progression of oral squamous cell carcinoma
Yuji Miyazaki et al.
JOURNAL OF ORAL SCIENCE (2015)
Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents
Fei Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome
Yasutaka Ueda et al.
BMC MEDICAL GENETICS (2014)
Synthesis of novel, azasugar-modified anthraquinone derivatives and their cytotoxicity
Ping-Zhu Zhang et al.
CHINESE CHEMICAL LETTERS (2014)
Mutations in POT1 predispose to familial cutaneous malignant melanoma
L. Trigueros-Motos
CLINICAL GENETICS (2014)
Telomerase structure
Sara Sandin et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
Progress in structural studies of telomerase
Edward J. Miracco et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
Telomere Maintenance as a Target for Drug Discovery
Vijay Sekaran et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeting DNA-PKcs and telomerase in brain tumour cells
Resham Lal Gurung et al.
MOLECULAR CANCER (2014)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton et al.
LANCET ONCOLOGY (2014)
Telomere and telomerase in chronic liver disease and hepatocarcinoma
Lucia Carulli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Synthesis and biological evaluation of quinoline-imidazole hybrids as potent telomerase inhibitors: a promising class of antitumor agents
Yong-Tao Duan et al.
RSC ADVANCES (2014)
Natural products: A continuing source of novel drug leads
Gordon M. Cragg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetra-hydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors
Xin-Hua Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors
Yin Luo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Novel anticancer therapeutics targeting telomerase
Maria Ruden et al.
CANCER TREATMENT REVIEWS (2013)
Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent
Juan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Inhibition of Telomerase Recruitment and Cancer Cell Death
Mai Nakashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells
Aik Kia Khaw et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Total Synthesis of Dictyodendrins B and E
Jingjing Liang et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
Evaluation of the Interaction between Long Telomeric DNA and Macrocyclic Hexaoxazole (6OTD) Dimer of a G-quadruplex Ligand
Keisuke Iida et al.
MOLECULES (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
AKT Activation and Telomerase Reverse Transcriptase Expression Are Concurrently Associated with Prognosis of Gastric Cancer
Takamitsu Sasaki et al.
PATHOBIOLOGY (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Telomerase: central regulator of all of the hallmarks of cancer
Kee Chung Low et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer
Jae-il Roh et al.
ONCOTARGETS AND THERAPY (2013)
Tankyrase-1 function at telomeres and during mitosis is regulated by Polo-like kinase-1-mediated phosphorylation
G-H Ha et al.
CELL DEATH AND DIFFERENTIATION (2012)
G-Quadruplex Binding Ligands: from Naturally Occurring to Rationally Designed Molecules
Tuong Vy Thi Le et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents
Xin-Hua Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Dimeric 1,3-Phenylene-bis(piperazinyl benzimidazole)s: Synthesis and Structure-Activity Investigations on their Binding with Human Telomeric G-Quadruplex DNA and Telomerase Inhibition Properties
Akash K. Jain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
hTERT-based therapy: A universal anticancer approach (Review)
Mu-Han Lu et al.
ONCOLOGY REPORTS (2012)
In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs
Kyle R. Hukezalie et al.
PLOS ONE (2012)
Recent Patents on Anti-Telomerase Cancer Therapy
Apurva Agrawal et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents
Xin-Hua Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
Leo Kretzner et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Yan Xu
CHEMICAL SOCIETY REVIEWS (2011)
Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells
Cigir Biray Avci et al.
HEMATOLOGY (2011)
Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents
Xin-Hua Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Telomerase Inhibition Potentiates the Effects of Genotoxic Agents in Breast and Colorectal Cancer Cells in a Cell Cycle-Specific Manner
Raina A. Tamakawa et al.
CANCER RESEARCH (2010)
Revisiting the Hallmarks of Midwifery
Frances E. Likis
JOURNAL OF MIDWIFERY & WOMENS HEALTH (2010)
Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues
Hsu-Shan Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Telomeres and Telomerase: From Discovery to Clinical Trials
David R. Corey
CHEMISTRY & BIOLOGY (2009)
Cancer vaccination with telomerase peptide GV1001
Jon Amund Kyte
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Telomere maintenance and human bone marrow failure
Rodrigo T. Calado et al.
BLOOD (2008)
Immunogenicity of the hTERT540-548 peptide in cancer
Lynn Wenandy et al.
CLINICAL CANCER RESEARCH (2008)
5-N-Methylated Quindoline Derivatives as Telomeric G-Quadruplex Stabilizing Ligands: Effects of 5-N Positive Charge on Quadruplex Binding Affinity and Cell Proliferation
Yu-Jing Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells
Bertrand Brassart et al.
MOLECULAR PHARMACOLOGY (2007)
Mechanism of acridine-based telomerase inhibition and telomere shortening
Mekala Gunaratnam et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism
P. Phatak et al.
BRITISH JOURNAL OF CANCER (2007)
Core-shell and segmented polymer-metal composite nanostructures
Michal Lahav et al.
NANO LETTERS (2006)
Potent inhibition of human telomerase by U-73122
Yi-Jui Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Total synthesis of (R)-telomestatin
Takayuki Doi et al.
ORGANIC LETTERS (2006)
Telomeres and telomerase as targets for anticancer drug development
KA Olaussen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest
VL Bae-Jump et al.
GYNECOLOGIC ONCOLOGY (2006)
The telomeric PARP, tankyrases, as targets for cancer therapy
H Seimiya
BRITISH JOURNAL OF CANCER (2006)
Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length
R Nakai et al.
CHEMISTRY & BIOLOGY (2006)
Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models
YH Li et al.
CLINICAL CANCER RESEARCH (2005)
Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase
JL Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells
SH Choi et al.
CANCER LETTERS (2005)
Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT)
D Soldateschi et al.
JOURNAL OF BIOTECHNOLOGY (2005)
Telomeres and human disease: Ageing, cancer and beyond
MA Blasco
NATURE REVIEWS GENETICS (2005)
The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function
AM Burger et al.
CANCER RESEARCH (2005)
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulator
G Kaur et al.
CLINICAL CANCER RESEARCH (2004)
Function, replication and structure of the mammalian telomere
D Broccoli
CYTOTECHNOLOGY (2004)
Dictyodendrins A-E, the first telomerase-inhibitory marine natural products from the sponge Dictyodendrilla verongiformis
K Warabi et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate
E Pascolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity
SM Gowan et al.
MOLECULAR PHARMACOLOGY (2002)
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells
M Suenaga et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
A highly selective telomerase inhibitor limiting human cancer cell proliferation
K Damm et al.
EMBO JOURNAL (2001)
Interaction of deoxyguanosine nucleotide analogs with human telomerase
SW Tendian et al.
MOLECULAR PHARMACOLOGY (2000)
G-quadruplex DNA: a potential target for anti-cancer drug design
HY Han et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells
M Folini et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
分享论文
